Expression of poly(Adenosine Diphosphate-Ribose) polymerase protein in breast cancer
Background: The use of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors for breast cancer (BC) therapy is the subject of debate, and there is an urgent need to understand much the expression and prognostic role of the PARP1 protein. In this study, we have compared the expression of PA...
Saved in:
Main Authors: | Akanksha (Author), Shashi Prakash Mishra (Author), Amrita Ghosh Kar (Author), J S Karthik (Author), Aviral Srivastava (Author), Rahul Khanna (Author), Ram Niwas Meena (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition
by: Audeh MW
Published: (2014) -
Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
by: Chia-Hao Liu, et al.
Published: (2017) -
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020) -
The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis
by: Samuel García, et al.
Published: (2015) -
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting
by: Bobbie J. Rimel, et al.
Published: (2024)